LEIFRAS Co., Ltd. Obtains Membership with the Nippon Sport Policy Commission
To Support National Sports Policy and Accelerate Community-Based Transition of School Club Activities TOKYO, March 18, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and community engagement, is pleased to announce that it has obtained membership with the Nippon Sport Policy Commission ("NSPC"), a...
ProtectHealth strengthen PeKa b40 health screening promotion with Hospital Shah Alam staff in Program Ziarah MADANI
SHAH ALAM, Malaysia, March 18, 2026 /PRNewswire/ -- ProtectHealth Corporation Sdn. Bhd., as an implementing agency under the Ministry of Health Malaysia (MOH), continues to strengthen efforts to promote the Skim Peduli Kesihatan for the B40 group during the Program Ziarah MADANI at Hospital Shah Alam. MADANI Ziarah Programme x PeKa B40: A...
2026 International Academicians Hong Kong Forum to be Held on April 14: Gathering Global Wisdom to Chart a New Blueprint for AI-Empowered Health and Higher Education
HONG KONG, March 18, 2026 /PRNewswire/ -- Jointly organized by the International Alliance of Academicians (IAA) and the Hong Kong Association of Overseas-Returned Scholars (HKAORS), the 2026 International Academicians Hong Kong Forum will take place on 14 April at the Grand Hyatt Hong Kong. The Forum has received strong support from the Hong Kong Special Administrative Region (HKSAR) Government,...
Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited
SHANGHAI, March 18, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into a letter of intent (the "Letter of Intent") with Hasten Biopharmaceuticals (Asia) Limited (the ''Seller'') in relation to the possible acquisition (the ''Possible...
North London Collegiate School (Singapore) Student Achieves Academic Milestone with Peer-Reviewed Journal Publication
Saket Subramaniam of North London Collegiate School (Singapore) publishes peer-reviewed medical research on colorectal cancer liver metastasis in the American Journal of Student Research. SINGAPORE, March 18, 2026 /PRNewswire/ -- North London Collegiate School (Singapore) celebrates the remarkable academic achievement of Grade 11 student Saket Subramaniam, whose research has been published in the peer-reviewed American Journal of Student Research. ...
Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGager™ TCEs
SHANGHAI and HONG KONG, March 18, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that it will present results from three preclinical...
Vieworks to Debut VISQUE DPS LH210 at USCAP 2026, a Single Scanner for Both Cytology and Histology
High-throughput, mid capacity LH210 expands the VISQUE DPS lineup with fast scanning, optimized data size, and scalable digital pathology workflow ANYANG, South Korea, March 18, 2026 /PRNewswire/ -- Vieworks, a global provider of advanced imaging solutions, will participate in USCAP 2026 (United States & Canadian Academy of Pathology Annual Meeting), held from March 23 to 25 at the Henry...
Breakthrough at 2026 AACR! Senhwa Biosciences’ CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy
TAIPEI and SAN DIEGO, March 18, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that its first-in-class investigational drug Pidnarulex (CX-5461) has demonstrated a significant research breakthrough in the field of photodynamic...
Health In Tech and Amazon Web Service Advanced Tier Service Partner Ciklum Announce Strategic Collaboration to Accelerate Development of AI-Driven InsurTech Platform
STUART, Fla., March 18, 2026 /PRNewswire/ -- Health In Tech, Inc. (the "Company" or "Health In Tech") (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced a strategic collaboration with Ciklum, a global AI-powered experience engineering and software development firm, to enhance the Company's AI-driven InsurTech platform. The HIT's platform...
Zylox-Tonbridge Reports 2025 Annual Results with Revenue Exceeding RMB 1.06 Billion and Net Profit Up 143.7% Year-over-Year
HANGZHOU, China, March 18, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, "Zylox-Tonbridge" or the "Company") today announced its annual results for the year ended December 31, 2025. In 2025, the Company delivered another year of strong growth and materially improved profitability. Revenue rose 35.1% year-over-year to RMB 1.06 billion, while net profit increased 143.7% year-over-year to...
